DD201773A5 - Verfahren zur herstellung eines neuen cinnamoylzimtsaeurederivats - Google Patents

Verfahren zur herstellung eines neuen cinnamoylzimtsaeurederivats Download PDF

Info

Publication number
DD201773A5
DD201773A5 DD81234330A DD23433081A DD201773A5 DD 201773 A5 DD201773 A5 DD 201773A5 DD 81234330 A DD81234330 A DD 81234330A DD 23433081 A DD23433081 A DD 23433081A DD 201773 A5 DD201773 A5 DD 201773A5
Authority
DD
German Democratic Republic
Prior art keywords
group
acid
lower alkyl
formula
alkyl group
Prior art date
Application number
DD81234330A
Other languages
German (de)
English (en)
Inventor
Francois Picart
Original Assignee
Sori Soc Rech Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sori Soc Rech Ind filed Critical Sori Soc Rech Ind
Publication of DD201773A5 publication Critical patent/DD201773A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD81234330A 1980-10-23 1981-10-23 Verfahren zur herstellung eines neuen cinnamoylzimtsaeurederivats DD201773A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8022693A FR2492815A1 (fr) 1980-10-23 1980-10-23 Nouveau derive d'acide cinnamoyl-cinnamique, son procede de preparation et son application en therapeutique

Publications (1)

Publication Number Publication Date
DD201773A5 true DD201773A5 (de) 1983-08-10

Family

ID=9247239

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81234330A DD201773A5 (de) 1980-10-23 1981-10-23 Verfahren zur herstellung eines neuen cinnamoylzimtsaeurederivats

Country Status (13)

Country Link
US (1) US4421927A (es)
EP (1) EP0051514B1 (es)
JP (1) JPS57126441A (es)
KR (1) KR830007484A (es)
AT (1) ATE5397T1 (es)
CS (1) CS231183B2 (es)
DD (1) DD201773A5 (es)
DE (1) DE3161510D1 (es)
ES (1) ES8301196A1 (es)
FR (1) FR2492815A1 (es)
GR (1) GR74679B (es)
HU (1) HU185463B (es)
ZA (1) ZA817275B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544666A (en) * 1983-04-22 1985-10-01 Phyton/Ag, Inc. Chemotherapeutic agents for the control of plant diseases
US4673687A (en) * 1983-04-22 1987-06-16 Source Technology Biologicals, Inc. New chemotherapeutic agents for the control of plant and animal diseases
SE8400239D0 (sv) * 1984-01-19 1984-01-19 Pharmacia Ab Nya arylettiksyraderivat
GB2163159B (en) * 1984-08-13 1987-10-14 Oreal 1-substituted derivatives of 4-methoxy-2, 3, 6-trimethylbenzene, process for their preparation and medicinal and cosmetic compositions containing them
US4885282A (en) * 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
IL112205A0 (en) * 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
US5610185A (en) * 1995-02-17 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
EP0998939A1 (en) * 1998-09-09 2000-05-10 The School Of Pharmacy, University Of London Chalcone plant extracts for use in therapy
WO2008144933A1 (en) * 2007-05-29 2008-12-04 Université de Montréal Cinnamoyl inhibitors of transglutaminase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
JPS5111748A (en) * 1974-07-16 1976-01-30 Taisho Pharmaceutical Co Ltd Suchirubenjudotaino seizoho
US4124724A (en) * 1975-12-08 1978-11-07 Agoro John W Crystalline caffeic acid derivatives and compositions and method for treating snakebite
US4190671A (en) * 1977-03-17 1980-02-26 Biorex Laboratories Limited Chalcone derivatives
US4163859A (en) * 1977-07-18 1979-08-07 G. D. Searle & Co. Phenoxyldialkyl acetic acids and esters

Also Published As

Publication number Publication date
JPS57126441A (en) 1982-08-06
CS769381A2 (en) 1984-02-13
CS231183B2 (en) 1984-10-15
FR2492815A1 (fr) 1982-04-30
ATE5397T1 (de) 1983-12-15
ZA817275B (en) 1982-10-27
DE3161510D1 (en) 1983-12-29
GR74679B (es) 1984-07-03
HU185463B (en) 1985-02-28
KR830007484A (ko) 1983-10-21
ES506471A0 (es) 1982-11-16
US4421927A (en) 1983-12-20
EP0051514A1 (fr) 1982-05-12
EP0051514B1 (fr) 1983-11-23
ES8301196A1 (es) 1982-11-16

Similar Documents

Publication Publication Date Title
EP0188749B1 (de) Fumarsäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3690187C2 (de) Naphthalinderivate mit retinoider Wirkung, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische und kosmetische Mittel
AT395714B (de) Verfahren zur herstellung von neuen aromatischen heterocyclischen verbindungen
DE69205725T2 (de) Iminoderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Tiermedizin und in der Kosmetik.
US4153803A (en) Cholesterol-lowering phenoxyalkanoic acid esters
DE69221614T2 (de) Neue aromatische und polycyclische verbindungen und ihre verwendung in der human- oder tiermedizin und in kosmetika
DD158773A5 (de) Verfahren zur herstellung neuer glycerol-deri vate
EP0084667B1 (de) Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
DE3202100A1 (de) Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE69021902T2 (de) 1-Benzyl-3-hydroxymethylindazol-Äther mit aliphatischen 2-Hydroxysäuren.
CH656800A5 (de) Immunomodulierendes mittel.
DD201773A5 (de) Verfahren zur herstellung eines neuen cinnamoylzimtsaeurederivats
DE60013947T2 (de) (Poly)thia-alkin-Verbindungen und ihre Derivate, diese enthaltende Zusammensetzungen und ihre Anwendung
DE69232270T2 (de) Benzimidazol-derivate, verfahren zu ihrer herstellung und ihre anwendung in den gebieten therapeutik und kosmetik
EP0009777B1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0004522B1 (de) Neue dilignolähnliche Verbindungen, dilignolähnliche Verbindungen zur Verwendung bei der Behandlung von Lebererkrankungen sowie diese enthaltende pharmazeutische Präparate
CH621780A5 (es)
LU83138A1 (de) Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung
EP0033095A1 (de) 5-Amino-tetrazol-Derivate von Retinsäuren, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0009776B1 (de) N-Monohydroxypropylamide, N-Dihydroxypropylamide und deren Acetonoide der all-E- und 13-Z-Retinsäure, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE1926359A1 (de) oxylkansaeuren
CH650241A5 (de) Phenylessigsaeurederivate, ihre herstellung und pharmazeutische praeparate.
DD251339A5 (de) Verfahren zur herstellung von neuen phenolderivaten
EP0199985A2 (de) Neue Benzoesäurederivate, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
DE2557517C3 (de) Phenylessigsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel